GILEAD SCIENCES, INC. Cash
GILEAD SCIENCES, INC. (GILD) had Cash of $2.00 billion as of 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2018-08-06
- 2018-06-30: Cash $2.00B.
- 2018-03-31: Cash $2.80B.
- 2017-12-31: Cash $2.40B.
- 2017-09-30: Cash $2.00B.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2018-06-30 | $2.00B 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $2.80B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.40B 10-Q · filed 2018-08-06 | |
| 2017-09-30 | $2.00B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.80B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $2.20B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $2.50B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $2.40B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.00B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $4.10B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $2.70B 10-K · filed 2017-02-27 | |
| 2015-09-30 | $1.90B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $1.80B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $2.70B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $2.10B 10-K · filed 2016-02-24 | |
| 2014-09-30 | $1.15B 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $2.84B 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $1.35B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $622.00M 10-K · filed 2015-02-25 | $621.80M 10-K · filed 2014-02-25 |
| 2013-09-30 | $443.60M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $340.00M 10-Q · filed 2013-08-01 | |
| 2012-12-31 | $387.30M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |